FIELD: medicine.
SUBSTANCE: what is described is a biomaterial having a multi-dimensional structure and comprising differentiated MSCs tissue and demineralised bone matrix, wherein the above demineralised bone matrix is dispersed in the differentiated MSCs tissue; a method for preparing and using the same is also presented.
EFFECT: biomaterial is processed as needed and has the mechanical properties required for implantation into the natural involved region.
17 cl, 6 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOCOMPOSITE SPHEROID FOR BONE REPAIR AND METHOD OF ITS PREPARATION | 2020 |
|
RU2744732C1 |
| 3D IN VITRO TWO-PHASE OSTEOCHONDRAL CONSTRUCT | 2013 |
|
RU2615439C2 |
| METHOD FOR RECOVERING RESORBED ALVEOLAR BONE TISSUE WITH A BIOENGINEERED STRUCTURE OF DECELLULARIZED HUMAN DENTAL TISSUES | 2019 |
|
RU2716594C1 |
| STEM CELLS AND MATRICES OBTAINED FROM ADIPOSE TISSUE | 2000 |
|
RU2306335C2 |
| METHOD FOR THE PRODUCTION OF SPHEROIDS FROM CULTURED CELLS OF THE PERIOSTEUM TO ENSURE REPARATIVE OSTEOGENESIS | 2020 |
|
RU2744664C1 |
| METHOD OF BIOFABRICATION OF A TRANSPLANT IN THE FORM OF CELL SPHEROIDS FOR REGENERATIVE TECHNOLOGIES FOR RESTORING A SUBJECT'S CARTILAGE BASED ON THE SUBJECT'S OWN COSTAL CARTILAGE PERICHONDRIUM AND MULTIPOTENT MESENCHYMAL STROMAL BONE MARROW CELLS OF THE SAME SUBJECT | 2022 |
|
RU2800991C2 |
| THREE-DIMENSIONAL MATRIXES FROM STRUCTURED POROUS MONETITE FOR TISSUE ENGINEERING AND BONE REGENERATION AND METHOD OF THEIR OBTAINING | 2009 |
|
RU2491960C9 |
| METHOD FOR OBTAINING TISSUE-ENGINEERED PERICHONDRIUM TRANSPLANT BASED ON CELL SPHEROIDS | 2022 |
|
RU2807692C2 |
| METHOD FOR REPAIRING LONG BONE DEFECTS OF CRITICAL SIZE | 2013 |
|
RU2545993C2 |
| METHOD OF TRANSPLANTING BIOCOMPOSITE SPHEROIDS TO ENSURE THE POSSIBILITY OF RESTORING THE INTEGRITY OF THE BONE IN CASE OF DEFECTS THAT EXCEED THE CRITICAL SIZE | 2020 |
|
RU2744756C1 |
